Nano-X Imaging Ltd. (NNOX)

AI-powered earnings prediction for Nano-X Imaging Ltd. (NNOX).

2.43
+1.67%
USD, 2 days ago
Market Cap
162.48M
Google

Company Overview

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide and obtain remote interpretations of imaging data; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. The company was founded in 2011 and is headquartered in Petah Tikva, Israel.

Sector
Healthcare
Industry
Medical Devices
Phone
972 3 373 59202
Headquarters
94 Shlomo Shmeltzer Road
Petah Tikva, 4970602
Israel
Full-Time Employees
165

Key Metrics

Forward P/E
-8.15
Price to Book
1.04
Beta
1.36
Profit Margin
0.00%
Gross Margin
-98.04%
Return on Equity
-34.75%
Return on Assets
-20.04%
Earnings Growth
N/A
Revenue Growth
13.70%

Financial Health

Total Cash
$45.19M
Total Debt
$7.88M
Debt to Equity
5.03
Current Ratio
4.14
Free Cash Flow
$-26877750.00
Operating Cash Flow
$-40911000.00

Analyst Recommendations

Target Price (Mean)
$7.40
Target High
$10.60
Target Low
$5.00
Recommendation
none
Analyst Coverage
4 Analysts

Trading Ideas

Related Stocks